ConductScience.org, home

Gene · 51430

SUCO: SUN domain containing ossification factor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. SUCO: SUN domain containing ossification factor. Genes, record 51430. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51430

On this page

Gene

Symbol
SUCO
HGNC
Name
SUN domain containing ossification factor
HGNC
NCBI Gene ID
51430
NCBI Gene
HGNC ID
HGNC:1240
HGNC
Ensembl
ENSG00000094975
NCBI Gene
Aliases
C1orf9, CH1, OPT, SLP1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UBS9SUN domain-containing ossification factor1,2540Ensembl, GeneID, HGNC

Source UniProt

Patents20

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-192241Q9UBS9Espacenet
EP 4641201 A22025-10-291813Q9UBS9Espacenet
JP 2025529142 A2025-09-044517Q9UBS9Espacenet
US 12371689 B22025-07-294517Q9UBS9Espacenet
JP 2025102886 A2025-07-0893Q9UBS9Espacenet
JP 2025517969 A2025-06-121813Q9UBS9Espacenet
JP 2025517970 A2025-06-122241Q9UBS9Espacenet
WO 2025040788 A12025-02-2726Q9UBS9Espacenet
JP 2024544676 A2024-12-0326Q9UBS9Espacenet
EP 4441083 A22024-10-0926Q9UBS9Espacenet

1 to 10 of 20

See all 20 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,162

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSUCO papersNewest fiscal year
ZIAAI005022Antibody Neutralization Mechanisms82025
UM1AI144462Consortium for HIV/AIDS Vaccine Development72025
P30GM133894A Synchrotron Radiation Structural Biology Resource62025
R01CA204484Novel Enediyne-Based Antibody-Drug Conjugates for Cancers62025
P01AI100148Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies52025
P20GM113132The Institute for Biomolecular Targeting42025
P30CA021765Cancer Center Support Grant (CCSG)42025
P30GM124169ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE)42025
UL1TR002243Vanderbilt Institute for Clinical and Translational Research (VICTR)42025
ZIAAI001155Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies42025

1 to 10 of 1,162Source NIH's project files

See all 1,162 nih grants

Papers1,981

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC-MS/MS.Rapid Commun Mass Spectrom202642635074PubTator, text miningPubMed
Reconstructed amphibian heavy-chain constant regions support a mosaic origin of IgXA with IgY-like CH1-CH2, an intermediate CH3, and an IgM-like CH4.Immunogenetics202642319471PubTator, text miningPubMed
Simulation study of layer-to-layer NBTI degradation non-uniformity in GAA multi-channel nanosheet FETs.Nanotechnology202642229463PubTator, text miningPubMed
An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity.Cell Press Blue202642147490PubTator, text miningPubMed
Divergent disulfide bond architecture defines two IgY subclasses in snakes.Dev Comp Immunol202642031188PubTator, text miningPubMed
Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview.Mol Neurobiol202641894093PubTator, text miningPubMed
Targeted Inactivation of an α/β Hydrolase Gene Enables Discovery of Heterodimeric Nenestatins.Mar Drugs202641892962PubTator, text miningPubMed
High-throughput high content quantification of HIV-1 viral infectious output.PLoS One202641886485PubTator, text miningPubMed
Structure-based calculation of excipient effects on the viscosity of concentrated antibody solutions.MAbs202641863436PubTator, text miningPubMed
Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer.Cell Rep Med202641850238PubTator, text miningPubMed

1 to 10 of 1,981

See all 1,981 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/51430

GET https://conductscience.org/api/genes/v1/51430/patents